Cited 7 times in
Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.